Mitomycin C Intravascular Chemoembolization (MICE) versus Fine Needle Diathermy (FND) for the Treatment of Corneal Neovascularization: A Comparative Study.

Mitomycin C Intravascular Chemoembolization versus Fine Needle Diathermy for the Treatment of Corneal Neovascularization: A Comparative Study.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202602897516823

Enrollment

Registered

2026-02-26

Start date

2024-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Mitomycin C Intravascular Chemoembolization

Fine Needle Diathermy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 18-70 years Corneal neovascularization due to trauma, infection or lipid keratopathy

Exclusion criteria

Exclusion criteria: History of previous interventions for corneal neovascularization Presence of active ocular infection or inflammation. Concurrent ocular or systemic diseases affecting corneal integrity or healing

Design outcomes

Primary

Measure	Time frame
Reduction in neovascularization area;Best Corrected Visual Acuity	—

Secondary

Measure	Time frame
Postoperative complications;Recurrence of neovascularization	—

Countries

Egypt

Contacts

Public ContactReem Dessouky

Assistant Professor of Ophthalmology Zagazig University

reem.amir@medicine.zu.edu.eg+201227297952

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026